Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22824
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaad, E. D.-
dc.contributor.authorBUYSE, Marc-
dc.date.accessioned2016-12-01T11:04:26Z-
dc.date.available2016-12-01T11:04:26Z-
dc.date.issued2016-
dc.identifier.citationANNALS OF ONCOLOGY, 27(8), p. 1653-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/1942/22824-
dc.description.abstract6. Yoon SH, Kim KW, Goo JM, Kim DW, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 2016; 53: 5-15. 7. Marten K, Auer F, Schmidt S et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur-
dc.language.isoen-
dc.publisherELSEVIER-
dc.rights© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.-
dc.titleResponse to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'-
dc.typeJournal Contribution-
dc.identifier.issue8-
dc.identifier.spage1653-
dc.identifier.volume27-
local.bibliographicCitation.jcatA1-
dc.description.notes[Saad, E. D.; Buyse, M.] Int Drug Dev Inst, Louvain La Neuve, Belgium. [Saad, E. D.] Dendrix Res, Sao Paulo, Brazil. [Buyse, M.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium.-
local.publisher.placeRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1093/annonc/mdw196-
dc.identifier.isi000383182800046-
local.provider.typePdf-
local.uhasselt.internationalyes-
item.accessRightsRestricted Access-
item.contributorSaad, E. D.-
item.contributorBUYSE, Marc-
item.fulltextWith Fulltext-
item.fullcitationSaad, E. D. & BUYSE, Marc (2016) Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'. In: ANNALS OF ONCOLOGY, 27(8), p. 1653.-
item.validationecoom 2017-
crisitem.journal.issn0923-7534-
crisitem.journal.eissn1569-8041-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S0923753419347349-main.pdf
  Restricted Access		Published version52.6 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

56
checked on Sep 7, 2022

Download(s)

52
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.